Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases

Neuroendocrine tumor (NET) patients must be adequately staged in order to improve a multidisciplinary approach and optimal management for metastatic disease. Currently available imaging studies include somatostatin receptor scintigraphy, like OctreoScan®, computed tomography (CT), scans and magnetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cossetti, Rachel Jorge D, Bezerra, Regis Otaviano França, Gumz, Brenda, Telles, Adriana, Costa, Frederico P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472201/
https://www.ncbi.nlm.nih.gov/pubmed/22591909
http://dx.doi.org/10.1186/1477-7819-10-82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472201/
https://www.ncbi.nlm.nih.gov/pubmed/22591909
http://dx.doi.org/10.1186/1477-7819-10-82

Ejemplares similares